Status:
UNKNOWN
Direct Anterior Versus Posterior Total Hip Arthroplasty Surgical Approaches
Lead Sponsor:
New Lexington Clinic
Collaborating Sponsors:
Biomet Orthopedics, LLC
Conditions:
Osteoarthritis
Avascular Necrosis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Hip replacement is a common surgical procedure performed to relieve the pain and disability. In general, the surgery consists of replacing the diseased or damaged joint surfaces of the hip with metal ...
Eligibility Criteria
Inclusion
- Between ages of 18 and 85
- End stage hip joint degeneration
- Has elected to undergo primary total hip arthroplasty
Exclusion
- Undergoing revision arthroplasty
- Inflammatory or rheumatoid arthritis
- Patients with confounding medical conditions that are not expected to survive for the duration of follow-up (10 years)
- Body Mass Index greater than 40 kg/m2
- Age \< 18 or \> than 85
- Previous ipsilateral hip surgery including arthroscopic procedures
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01807494
Start Date
November 1 2012
End Date
February 1 2023
Last Update
October 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lexington Clinic
Lexington, Kentucky, United States, 40504